Figures & data
Figure 1 Years of first clinical study and approval for therapeutic monoclonal antibodies. *Two-year moving average. FDA, United States Food and Drug Administration.
![Figure 1 Years of first clinical study and approval for therapeutic monoclonal antibodies. *Two-year moving average. FDA, United States Food and Drug Administration.](/cms/asset/4cea064e-3582-4a34-93dd-5b9d7e2c3fc5/kmab_a_10913603_f0001.gif)
Table 1 Therapeutic monoclonal antibodies undergoing regulatory review or approved in the United States
Table 2 Mean (median) clinical and FDA approval phases for 23 therapeutic monoclonal antibodiesTable Footnote*